Neonatal screening
- 20 January 1996
- Vol. 312 (7024) , 182
- https://doi.org/10.1136/bmj.312.7024.182b
Abstract
# Performance is hard to monitor {#article-title-2} EDITOR,—We agree with Allison Streetly and colleagues that any additions to the established neonatal screening programme for phenylketonuria and congenital hypothyroidism should be assessed for effectiveness, including impact on the performance of the overall programme.1 But we would go further and suggest that such an assessment would prove difficult because of inherent problems with the existing neonatal screening programme, which need to be addressed first. Streetly and colleagues assume that 99% of babies are tested for phenylketonuria and congenital hypothyroidism, though the figure may be lower, at least in London, where coverage with …Keywords
This publication has 4 references indexed in Scilit:
- Survey of scope of neonatal screening in the United KingdomBMJ, 1995
- Variation in coverage by ethnic group of neonatal (Guthrie) screening programme in south LondonBMJ, 1994
- Audit of screening for congenital hypothyroidism.Archives of Disease in Childhood, 1992
- Review of neonatal screening programme for phenylketonuria.BMJ, 1991